← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #202 OF 1,000 MOST-CITED

Sanitation--buildings not clean, free of infestation

FDA cited this observation 115 times across 110 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs115
BY FISCAL YEAR
FY202611
FY202515
FY202413
FY202316
FY202216
FY20214
FY20203
FY201911
FY201818
FY20178

How FDA worded it — real examples

Buildings used in the manufacture, processing, packing or holding of drug products are not free of infestation by rodents, birds insects, and other vermin.

Viatris Pharmaceuticals LLC · Vega Baja, Puerto Rico · Drugs · 2026-05-18

Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition.

Sciegen Pharmaceuticals Inc · Hauppauge, New York · Drugs · 2026-05-15

Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition.

Custom Analytics LLC · Dalzell, South Carolina · Drugs · 2026-03-12

Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition and free of infestation by rodents, birds insects, and other vermin.

NEOLPHARMA, INC. · Caguas, Puerto Rico · Drugs · 2026-03-10

Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition.

Pharmaceutics International, Inc. · Cockeysville, Maryland · Drugs · 2026-03-06

Buildings used in the manufacture, processing, packing or holding of drug products are not free of infestation by rodents, birds insects, and other vermin.

Sharp Sterile Manufacturing, LLC · Lee, Massachusetts · Drugs · 2026-03-05

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination controlPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →